Skip to main content

Peer Review reports

From: Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment

Original Submission
7 Feb 2021 Submitted Original manuscript
14 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report
28 Jun 2021 Author responded Author comments - Wenqing Yang
Resubmission - Version 2
28 Jun 2021 Submitted Manuscript version 2
7 Jul 2021 Reviewed Reviewer Report
10 Jul 2021 Reviewed Reviewer Report
3 Sep 2021 Author responded Author comments - Wenqing Yang
Resubmission - Version 3
3 Sep 2021 Submitted Manuscript version 3
24 Sep 2021 Reviewed Reviewer Report
29 Sep 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Sep 2021 Editorially accepted
22 Oct 2021 Article published 10.1186/s12885-021-08859-5

You can find further information about peer review here.

Back to article page